Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis

Targeted kinase inhibitors improve the prognosis of lung cancer patients with ALK alterations (ALK+). However, due to the emergence of acquired resistance and varied clinical trajectories, early detection of disease progression is warranted to guide patient management and therapy decisions. We utili...

Descripción completa

Detalles Bibliográficos
Autores principales: Angeles, Arlou Kristina, Christopoulos, Petros, Yuan, Zhao, Bauer, Simone, Janke, Florian, Ogrodnik, Simon John, Reck, Martin, Schlesner, Matthias, Meister, Michael, Schneider, Marc A., Dietz, Steffen, Stenzinger, Albrecht, Thomas, Michael, Sültmann, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651695/
https://www.ncbi.nlm.nih.gov/pubmed/34876698
http://dx.doi.org/10.1038/s41698-021-00239-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651695/
https://www.ncbi.nlm.nih.gov/pubmed/34876698
http://dx.doi.org/10.1038/s41698-021-00239-3

Ejemplares similares